Our assessment
Bottom line
SENSORA has meaningful prospective and external evidence for individual functions, especially low-ejection-fraction screening. The platform should be assessed algorithm by algorithm because performance, predictive value, signal quality, and referral consequences differ by configuration and setting.
Based on public sources. RIR did not independently test this product. This is not an endorsement or recommendation.
What the evidence supports
Reviewed sources establish a regulated AI platform for specified heart sound and ECG findings using compatible Eko devices.
What remains uncertain
Current algorithm performance by device, operator, population, and care pathway requires configuration-specific review.
How it was studied
SENSORA combines separately cleared algorithms for defined findings. The low-ejection-fraction function has prospective and multicenter observational evidence against echocardiography, including a four-network study of 2,960 adults. Murmur software has also undergone external evaluation against echocardiography.